The Impact of Digital Twin Technology on HbA1c Reduction and ASCVD Risk in Participants Enrolled for Type 2 Diabetes Remission: Outcomes of RCCT At 1 Year
Baseline Characteristics of Adults with Classic Congenital Adrenal Hyperplasia Enrolled in CAHtalyst, a Phase 3 Study of Crinecerfont, a Corticotropin-Releasing Factor Type 1 Receptor Antagonist